8-KEarnings & ResultsExhibits & Filings

REGENERON PHARMACEUTICALS, INC. 8-K Report, Financial Results (Aug 2, 2018)

Filed August 2, 2018For Securities:REGN

Summary

Regeneron Pharmaceuticals, Inc. (REGN) filed an 8-K on August 2, 2018, primarily to furnish a press release announcing its financial and operating results for the second quarter ended June 30, 2018. This filing provides investors with key performance indicators and updates on the company's financial condition for the period. The press release, attached as Exhibit 99.1, contains the detailed results that are central to understanding the company's recent performance and outlook. While the 8-K itself is brief, the furnished press release is the critical document for investors seeking information on Regeneron's Q2 2018 performance. Investors should review Exhibit 99.1 for specifics on revenue, earnings, product sales, pipeline developments, and any forward-looking statements made by the company. The filing's purpose is to ensure timely disclosure of these important operational and financial updates to the market.

Key Highlights

  • 1Regeneron announced its second quarter 2018 financial and operating results via a press release filed with the SEC.
  • 2The press release, dated August 2, 2018, is attached as Exhibit 99.1 to the 8-K filing.
  • 3This filing serves to provide investors with timely updates on the company's performance for the quarter ended June 30, 2018.
  • 4Investors should refer to Exhibit 99.1 for detailed financial and operational performance data.
  • 5The information furnished under Item 2.02 is not considered 'filed' for certain SEC provisions, but is crucial for market understanding.

Frequently Asked Questions

The main purpose of this 8-K filing is to furnish a press release that announces Regeneron's financial and operating results for the second quarter ended June 30, 2018. It ensures timely disclosure of these results to the public and investors.

The detailed financial and operating results for the second quarter of 2018 are contained within the press release, which is provided as Exhibit 99.1 to this 8-K filing.

This 8-K filing itself does not contain the specific financial figures. Instead, it references a press release (Exhibit 99.1) which is expected to detail the company's revenue, earnings, and other key financial and operational metrics for the quarter.

When information is furnished and not 'filed' under Section 18 of the Securities Exchange Act of 1934, it means that the company is not subject to the same liability for misstatements or omissions in that specific context. However, the information is still publicly disclosed and relevant for investors' decision-making, and could be incorporated into other filings that are formally 'filed'.